Researchers May Have Found a Way to Improve Mesothelioma Drug’s Effectiveness
A significant amount of research is dedicated to finding more effective approaches to malignant mesothelioma. Scientists are trying to determine the best surgical techniques, create better diagnostic tools and test the effects of various chemotherapy drugs. At Kazan, McClain, Lyons, Greenwood and Harley, we keep our ears to the ground for you, and we are excited about what we are hearing.
For example, some researchers decided to focus their investigation on improving the performance of the tools that are already available, such as cisplatin, which is one of the most common medications prescribed for mesothelioma patients. One team from Switzerland found that short-term starvation may actually give cisplatin a boost, according to a new study appearing in the journal BMC Cancer.
What does cisplatin do for mesothelioma patients?
There is no cure for
Our Recent Verdicts
- $29,500,000 Mesothelioma Verdict for User of Johnson & Johnson Baby Powder
- $117,000,000 Mesothelioma Verdict for Lifelong User of Johnson & Johnson Baby Powder
- $22,170,000 Mesothelioma Verdict for the Family of a Deceased Paint Maker
- $32,800,000 Mesothelioma Verdict for Former Machinist
- $27,342,500 Verdict for Former Wife of Insulator
Latest News
- Kazan Firm Wins $29.5 Million Mesothelioma Verdict Against Johnson & Johnson Mar 13, 2019
- What to Look for When Researching Mesothelioma Law Firms Feb 20, 2019
- Kazan Firm Wins $117 Million Johnson & Johnson’s Talc Baby Powder Mesothelioma Verdict Apr 11, 2018
- Kazan Law Is Proud to Support the 2018 International Mesothelioma Interest Group (iMig) Apr 9, 2018
- Kazan Law Applauds the Appointment of Judge Rafael Vazquez Feb 13, 2018